Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen

Vaccine

Volumn 29, Issue 10, 2011, Pages 1906-1912

  Nagendrakumar, Singanallur Balasubramanian ^a   Srinivasan, Villuppanoor Alwar ^a   Madhanmohan, Muthukrishnan ^a   Yuvaraj, Shanmugam ^a   Parida, Satya ^b   Di Nardo, Antonello ^b   Horsington, Jacquelyn ^b   Paton, David James ^b  

^a Indian Immunologicals Limited   (India)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Carrier status; Cross protection; FMDV; Relative homology; Serology

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CATTLE; CONTROLLED STUDY; CROSS PROTECTION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SEROLOGY; VACCINATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; CATTLE; CATTLE DISEASES; CROSS PROTECTION; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; NEUTRALIZATION TESTS; VIRAL VACCINES;

EID: 79951726539     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.127     Document Type: Article

References (28)

1. Brooksby J.B. Portraits of viruses: foot-and-mouth disease virus. Intervirology 1982, 18:1-23.
2. Cartwright B., Chapman W.G., Sharpe R.T. Stimulation of heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Res Vet Sci 1982, 32:338-342.
3. Rweyemamu M.M., Hingley P.J. Foot-and-mouth disease virus strain differentiation: analysis of the serological data. J Biol Stand 1984, 12:225-229.
4. Alonso A., Gomes M.P.D., Ramalho A.K., Allende R., Barahona H., Sondahl M., et al. Characterization of foot-and-mouth disease virus by monoclonal antibodies. Viral Immunol 1993, 6:219-228.
5. Kitching R.P., Rendle R., Ferris N.P. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Vaccine 1988, 6:403-408.
6. Paton D.J., Valarcher J.F., Bergmann I., Matlho O.G., Zakharov V.M., Palma E.L., et al. Selection of foot-and-mouth disease vaccine strains - a review. Rev Sci Tech OIE 2005, 24:981-993.
7. Dunn C.S., Samuel A.R., Pullen L.A., Anderson J. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 1998, 247:51-61.
8. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., Kihm U. Protective immune response against foot-and-mouth disease. J Virol 1992, 66:1835-1840.
9. Aggarwal N., Zhang Z., Cox S., Statham R., Alexandersen S., Kitching R.P., et al. Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom. Vaccine 2002, 20:2508-2515.
10. Barteling S.J., Swam H. The potent aqueous and double oil emulsion foot-and-mouth disease type O1 vaccines from European Vaccine Banks probably protect against all other O1 strains. Report of the European Commission for the Control of Foot-and-mouth disease. Session of the Research Group of the Standing Technical Committee, Appendix 13 2006, 90-94.
11. Mattion N., Konig G., Seki C., Smitsaart E., Maradei E., Robiolo B., et al. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine 2004, 22:4149-4162.
12. Brehm K.E., Kumar N., Thulke H.-H., Haas B. High potency vaccines induce protection against heterologous challenge with foot and mouth disease virus. Vaccine 2008, 26:1681-1687.
13. Samuel A.R., Knowles N.J. Serological and biochemical study of an isolate of foot-and-mouth disease virus type A from Bavaria in 1984. Rev Sci Tech OIE 1988, 7:365-373.
14. Doel T.R., Mowat G.N. An international collaborative study on foot and mouth disease virus assay methods 2. Quantification of 146S particles. J Biol Stand 1985, 13:335-344.
15. Rweyemamu M.M., Hingley P.J. Food and mouth disease virus strain differentiation: analysis of the serological data. J Biol Stand 1984, 12:191-194.
16. Snowdon W.A. Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 1966, 210:1079-1080.
17. Ferris N.P., Dawson M. Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular disease. Vet Microbiol 1988, 16:201-209.
18. Reid S.M., Ferris N.P., Hutchings G.H., Zhang Z., Belsham G.J., Alexandersen S. Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J Virol Methods 2002, 105:67-80.
19. Reid S.M., Grierson S.S., Ferris N.P., Hutchings G.H., Alexandersen S. Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus. J Virol Methods 2003, 107:129-139.
20. Quan M., Murphy C.M., Zhang Z., Alexandersen S. Determinants of early foot-and-mouth disease virus dynamics in pigs. J Comp Pathol 2004, 131:294-307.
21. Golding S.M., Hedger R.S., Talbot P. Radial immuno-diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci 1976, 20:142-147.
22. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 1931, 162:480-487.
23. Wickham H. Ggplot2: elegant graphics for data analysis (use R) 2009, Springer-Verlan Inc., New York. 2nd printing ed.
24. Gardner M.J., Altman D.G., Machin D., Bryant T., Gardner S. Statistics with confidence 2000, BMJ Publishing, London. 2nd revised ed.
25. OIE (Office International des Epizooties/World Organisation for Animal Health) Foot and mouth disease. Manual of standards for diagnostic tests and vaccines 2008, Office International des Epizooties, Paris, France. OIE Standards Commission (Ed.).
26. Stellmann C., Terre J., Favre H., Brun A., Fontaine J. Comparison of foot and mouth disease vaccine potency testing on cattle in terms of the nature of the diluent. Arch Virol 1977, 54:61-74.
27. Aggarwal N., Barnett P.V. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. J Gen Virol 2002, 83:775-782.
28. Srinivasan V.A., Nagendrakumar S.B., Madhanmohan M., Maroudam V., Santhakumar P., Parida S., et al. Preliminary results to evaluate cross-protection between O1 Manisa and O1 Campos in cattle. Appendix 33. International control of foot-and-mouth disease: tools, trends and perspectives. EUFMD Report 2006. Appendix 30. Session of the Research Group of the Standing Technical Committee of EUFMD Paphos 2006.